Impact of COVID-19 Pandemic on Liquidity and Profitability of Pharmaceutical Firms in Europe (2018-2021)
dc.contributor.author | EL-Warflli, Mohammed | |
dc.contributor.author | Elkrghli, Sabri | |
dc.date.accessioned | 2023-08-13T08:09:52Z | |
dc.date.available | 2023-08-13T08:09:52Z | |
dc.date.issued | 2023-08-13 | |
dc.identifier.uri | http://repository.limu.edu.ly/handle/123456789/4830 | |
dc.language.iso | en_US | en_US |
dc.rights | Attribution 3.0 United States | * |
dc.rights.uri | http://creativecommons.org/licenses/by/3.0/us/ | * |
dc.title | Impact of COVID-19 Pandemic on Liquidity and Profitability of Pharmaceutical Firms in Europe (2018-2021) | en_US |
dc.type | Presentation | en_US |